Gx™ Breast and Ovarian Cancer Gene Testing

Sequence 15 high-risk breast and ovarian cancer susceptibility genes

Breast and Ovarian Cancer

The most common of all cancers to affect women is breast cancer, with as many as one-in-eight women contracting it during their lifetime. Approximately 10% of all breast cancer cases are due to DNA mutation(s), while risk for breast cancer can be further augmented by factors such as age, lifestyle choices, reproductive history and more.

Hereditary mutations in certain genes, such as BRCA1 and BRCA2, commonly result in the early-onset of breast cancer, recurrent breast cancer and breast cancer involving both breasts. Genes that are associated with breast cancer can often also cause ovarian cancer.

Gx-Breast and Ovarian Cancer Gene Testing (Gx™ BrOvCa)

Gx™ BrOvCa is a comprehensive hereditary breast and ovarian cancer risk assessment include germline sequencing of 15 genes, ATMBRCA1BRCA2BRIP1CDH1MLH1MSH2MSH6PALB2PTENRAD51CRETSTK11TP53VHL.

Gx™ BrOvCa can identify the specific risk or cause factor for breast cancer. Identification of a specific genetic mutation provides important information for a better care in at least the following conditions:

  • Two primary breast cancers or clustering of breast and ovarian cancer.
  • Early-onset breast cancer (<50 years-of-age) or bilateral breast cancer.
  • Presence of male breast cancer.
  • Ovarian cancer at any age.

Option to test for a more extended Gx™ InhCa Gene Testing available